BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20660740)

  • 21. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel repair mechanisms in a renal ischaemia/reperfusion model: Subsequent saxagliptin treatment modulates the pro-angiogenic GLP-1/cAMP/VEGF, ANP/eNOS/NO, SDF-1α/CXCR4, and Kim-1/STAT3/HIF-1α/VEGF/eNOS pathways.
    Kamel NM; Abd El Fattah MA; El-Abhar HS; Abdallah DM
    Eur J Pharmacol; 2019 Oct; 861():172620. PubMed ID: 31437429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chlorogenic acid inhibits hypoxia-induced angiogenesis via down-regulation of the HIF-1α/AKT pathway.
    Park JJ; Hwang SJ; Park JH; Lee HJ
    Cell Oncol (Dordr); 2015 Apr; 38(2):111-8. PubMed ID: 25561311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic significance of HIF-1α, CXCR4, and VEGF expression in colon cancer.
    Wu Y; Jin M; Xu H; Shimin Z; He S; Wang L; Zhang Y
    Clin Dev Immunol; 2010; 2010():. PubMed ID: 20953377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of HIF-1alpha in proton-mediated CXCR4 down-regulation in endothelial cells.
    Melchionna R; Romani M; Ambrosino V; D'Arcangelo D; Cencioni C; Porcelli D; Toietta G; Truffa S; Gaetano C; Mangoni A; Pozzoli O; Cappuzzello C; Capogrossi MC; Napolitano M
    Cardiovasc Res; 2010 May; 86(2):293-301. PubMed ID: 20007689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor.
    Zagzag D; Krishnamachary B; Yee H; Okuyama H; Chiriboga L; Ali MA; Melamed J; Semenza GL
    Cancer Res; 2005 Jul; 65(14):6178-88. PubMed ID: 16024619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis.
    Teng F; Tian WY; Wang YM; Zhang YF; Guo F; Zhao J; Gao C; Xue FX
    J Hematol Oncol; 2016 Feb; 9():8. PubMed ID: 26851944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polycomb YY1 is a critical interface between epigenetic code and miRNA machinery after exposure to hypoxia in malignancy.
    Infante T; Mancini FP; Lanza A; Soricelli A; de Nigris F; Napoli C
    Biochim Biophys Acta; 2015 May; 1853(5):975-86. PubMed ID: 25644713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Yin and Yang of YY1 in tumor growth and suppression.
    Khachigian LM
    Int J Cancer; 2018 Aug; 143(3):460-465. PubMed ID: 29322514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of polypeptide extract from scorpion venom (PESV) on expression of HIF-1alpha and SDF-1/CXCR4 in repopulating H22 tumour tissue during chemotherapy treatment].
    Wang Z; Zhang W; Wu L; Jia Q; Wang Z; Zhang Y; Ning Y
    Zhongguo Zhong Yao Za Zhi; 2011 Jul; 36(13):1803-7. PubMed ID: 22032149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth.
    Liu H; Qiu Y; Pei X; Chitteti R; Steiner R; Zhang S; Jin ZG
    Sci Rep; 2020 Nov; 10(1):20493. PubMed ID: 33235311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway.
    Liang Z; Brooks J; Willard M; Liang K; Yoon Y; Kang S; Shim H
    Biochem Biophys Res Commun; 2007 Aug; 359(3):716-22. PubMed ID: 17559806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha.
    Shim H; Lau SK; Devi S; Yoon Y; Cho HT; Liang Z
    Biochem Biophys Res Commun; 2006 Jul; 346(1):252-8. PubMed ID: 16756955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression.
    Lee J; Park SY; Lee EK; Park CG; Chung HC; Rha SY; Kim YK; Bae GU; Kim BK; Han JW; Lee HY
    Clin Cancer Res; 2006 Nov; 12(21):6351-8. PubMed ID: 17085645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIF-1α/SDF-1/CXCR4 axis reduces neuronal apoptosis via enhancing the bone marrow-derived mesenchymal stromal cell migration in rats with traumatic brain injury.
    Guo K; Yao X; Wu W; Yu Z; Li Z; Ma Z; Liu D
    Exp Mol Pathol; 2020 Jun; 114():104416. PubMed ID: 32165091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysregulated Kras/YY1/ZNF322A/Shh transcriptional axis enhances neo-angiogenesis to promote lung cancer progression.
    Lin CC; Kuo IY; Wu LT; Kuan WH; Liao SY; Jen J; Yang YE; Tang CW; Chen YR; Wang YC
    Theranostics; 2020; 10(22):10001-10015. PubMed ID: 32929330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma.
    Petrella BL; Brinckerhoff CE
    Cancer Biol Ther; 2009 Jul; 8(14):1389-401. PubMed ID: 19483472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.
    Guiducci S; Manetti M; Romano E; Mazzanti B; Ceccarelli C; Dal Pozzo S; Milia AF; Bellando-Randone S; Fiori G; Conforti ML; Saccardi R; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2011 Nov; 70(11):2011-21. PubMed ID: 21821866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vinorelbine inhibits angiogenesis and 95D migration via reducing hypoxic fibroblast stromal cell-derived factor 1 secretion.
    Fang D; Sun L; Lin S; Zhou L; Su N; Yuan S; Yu B
    Exp Biol Med (Maywood); 2012 Sep; 237(9):1045-55. PubMed ID: 22946087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A radicicol derivative, KF58333, inhibits expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor, angiogenesis and growth of human breast cancer xenografts.
    Kurebayashi J; Otsuki T; Kurosumi M; Soga S; Akinaga S; Sonoo H
    Jpn J Cancer Res; 2001 Dec; 92(12):1342-51. PubMed ID: 11749701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.